Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the field of biopharmaceuticals, supplying promising developments across many health care and industrial apps. With its structural similarity to Obviously derived human serum albumin, OsrHSA offers a safer, more reliable alternative for therapeutic use, notably in drug sh